VBIV
$0.58
Revenue | $6.62Mn |
Net Profits | $-20.44Mn |
Net Profit Margins | -308.64% |
Vbi Vaccines Inc’s revenue jumped 1989.59% since last year same period to $6.62Mn in the Q3 2023. On a quarterly growth basis, Vbi Vaccines Inc has generated 820% jump in its revenue since last 3-months.
Vbi Vaccines Inc’s net profit jumped 27.18% since last year same period to $-20.44Mn in the Q3 2023. On a quarterly growth basis, Vbi Vaccines Inc has generated 54.19% jump in its net profits since last 3-months.
Vbi Vaccines Inc’s net profit margin jumped 96.52% since last year same period to -308.64% in the Q3 2023. On a quarterly growth basis, Vbi Vaccines Inc has generated 95.02% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -0.22 |
EPS Estimate Current Year | -0.22 |
Vbi Vaccines Inc’s earning per share (EPS) estimates for the current quarter stand at -0.22 - a -57.14% fall from last quarter’s estimates.
Vbi Vaccines Inc’s earning per share (EPS) estimates for the current year stand at -0.22.
Earning Per Share (EPS) | -1.01 |
Vbi Vaccines Inc’s earning per share (EPS) fell -1022.22% since last year same period to -1.01 in the Q3 2023. This indicates that the Vbi Vaccines Inc has generated -1022.22% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-14 | -0.14 | -1.01 | -621.43% |
2023-05-15 | -1.25 | -3.22 | -157.6% |
2023-08-14 | -2.16 | -5.05 | -133.8% |